Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
REBUILD-2 - I5Q-MC-CGAT( e): A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age with Chronic Migraine - the REBUILD-2 Study
Qaiser, Sharoon
(PI)
Neurology
Overview
Grants and Contracts Details
Status
Active
Effective start/end date
3/16/22
→
7/9/25
Funding
Eli Lilly and Company:
$63,879.00
View all
View less